KM
AGRX

Kalos Management’s Agile Therapeutics AGRX Stock Holding History

Kalos Management’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-8
Closed -$3K – 171
2022
Q1 		$3K Buy
+8
New +$5.11K ﹤0.01% 175
2021
Q4 		– Sell
-9
Closed -$15K – 291
2021
Q3 		$15K Sell
9
-1
-10% -$2.26K ﹤0.01% 292
2021
Q2 		$24K Hold
10
– – 0.01% 263
2021
Q1 		$35K Hold
10
– – 0.01% 293
2020
Q4 		$55K Hold
10
– – 0.02% 246
2020
Q3 		$58K Sell
10
-1
-9% -$5.73K 0.03% 226
2020
Q2 		$58K Hold
11
– – 0.02% 209
2020
Q1 		$42K Buy
+11
New +$63.1K 0.02% 199
2019
Q4 		– Sell
-9
Closed -$21K – 228
2019
Q3 		$21K Buy
+9
New +$22.2K 0.01% 196

Other funds holding AGRX

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return